Latest stories on RXRX
Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th
Business Insider50 · neutralgeneral
Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy?
The Motley Fool63 · neutralanalyst
Is Recursion Pharmaceuticals (RXRX) The Best Penny Stocks According to Billioanires?
Yahoo Finance57 · neutralanalyst
Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026?
The Motley Fool54 · neutralanalyst
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
The Motley Fool56 · neutralanalyst
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in June 2026
Seeking Alpha34 · bearishgeneral
Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool57 · neutralanalyst
1 of the Most Interesting AI Stocks in the Market Isn’t a Tech Company
Barchart58 · neutralproduct/pr
Recursion Shareholders Reelect Directors and Approve Governance Matters
TipRanks50 · neutralgeneral
RECURSION PHARMACEUTICALS, INC. (RXRX) files 8-K
SEC 8-K50 · neutralgeneral
Recursion Pharmaceuticals: Short-Trade Crowded But Near-Term Squeeze Not Guaranteed
Seeking Alpha42 · neutralgeneral
Recursion Pharmaceuticals, Inc. (RXRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha56 · neutralgeneral
Recursion (RXRX) Climbs 9.5% Ahead of Next Week’s Business Updates
Yahoo Top63 · neutralgeneral
Most and least shorted mid- to mega-cap healthcare stocks at the end of May
Seeking Alpha34 · bearishgeneral
Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Top57 · neutralanalyst
Recursion to Participate in Upcoming Investor Conferences | RXRX Stock News
StockTitan56 · neutralgeneral
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules | RXRX Stock News
StockTitan50 · neutralgeneral
Recursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now?
Yahoo Finance54 · neutralanalyst
Recursion Pharmaceuticals (RXRX) Hits 52-Week Low; Is It In Oversold Territory?
Yahoo Top42 · neutralgeneral
Morgan Stanley Raises its Price Target on Recursion (RXRX)
Yahoo Top61 · neutralanalyst
Recursion Pharmaceuticals (RXRX): 10 Unrivaled Penny Stocks to Buy Now
Yahoo Top57 · neutralanalyst
Recursion Pharmaceuticals (RXRX): Best AI Stocks Under $50 to Buy Right Now
Yahoo Top57 · neutralanalyst